Browse Geriatrics/Aging General
Filter Results
- By Article Category
- All Categories
- Clinical Cases (131)
- Other (92)
- Research (73)
- Commentary (35)
- Review (25)
- Perspective (14)
- By Date
- Past 10 years
- Past 20 years
- Past 50 years
- Past 100 years
- Complete archive (1812-present)
- Specific date range
Sort By:
- Newest
- Oldest
- Most Viewed
- Most Cited
Original Article
Registry of Transcatheter Aortic-Valve Implantation in High-Risk Patients
Aortic stenosis is now the most frequently diagnosed valvular disease. Surgical aortic-valve replacement is the definitive therapy for patients with severe symptomatic aortic stenosis. Operative mortality is low among selected elderly patients but increases with the number and severity of…
Correspondence
Bleeding Risk with Dabigatran in the Frail Elderly
To the Editor: Since July 1, 2011, the thrombin inhibitor dabigatran has been available in New Zealand for stroke prevention in patients with atrial fibrillation. There are no restrictions on prescribing, and access is free to patients through government funding. Approximately 7000 patients started…
- Free Full Text
Interactive Medical Case
A Startling Decline
An 89-year-old man presented with changes in cognition and personality. Six months earlier, he began to require help managing his finances and operating his computer. His family observed that he had a poor memory for recent events and found it difficult to express himself. During the next few…
- Free Full Text
- CME
An 89-year-old man was brought to the ER for evaluation of changes in his cognition and personality. He exhibited poor memory for recent events and difficulty expressing himself. Test your diagnostic and therapeutic skills at NEJM.org.
Clinical Problem-Solving
Worth a Second Look
Foreword. In this Journal feature, information about a real patient is presented in stages (boldface type) to an expert clinician, who responds to the information, sharing his or her reasoning with the reader (regular type). The authors' commentary follows. Stage. A 72-year-old man presented to his…
Case Records of the Massachusetts General Hospital
Case 36-2011 — A 93-Year-Old Woman with Shortness of Breath and Chest Pain
Presentation of Case. Dr. Pooja Agrawal (Emergency Medicine): A 93-year-old woman was seen in the emergency department at this hospital because of chest pain and shortness of breath. The patient had been in her usual state of health, with hypertension and chronic renal insufficiency, until the…
- Video
Special Article
Emergency Hospitalizations for Adverse Drug Events in Older Americans
Decreasing the number of preventable rehospitalizations by 20% by the end of 2013 is a goal of the $1 billion federal initiative Partnership for Patients, and the pursuit of this goal represents an opportunity to reduce harm to patients and reduce health care costs. Adverse drug events are a direct…
- Free Full Text
Correspondence
Acutely Injured Patients on Dabigatran
To the Editor: Trauma remains the fourth leading cause of death in the United States, with 40,000 deaths annually in persons over the age of 65. U.S. trauma centers are seeing an increasing number of severely injured elderly patients, and hemorrhagic complications and head injuries account for a…
- Free Full Text
Case Records of the Massachusetts General Hospital
Case 34-2011 — A 75-Year-Old Man with Memory Loss and Partial Seizures
Presentation of Case. A 75-year-old physician was seen in an outpatient office at this hospital because of memory loss and episodes of near-syncope. The patient had been generally well, except for mild and gradual memory loss, until 7 months earlier, when episodes of diffuse tingling and a…
Clinical Implications of Basic Research
Can Age-Associated Memory Decline Be Treated?
Many older adults believe that their memory is not as good as it was when they were younger. An epidemiologic study in Finland documented that 76% of persons over the age of 60 years reported problems with their memory. Age-associated memory decline has been well studied and refers to changes in…
Perspective
Reducing Unnecessary Hospitalizations of Nursing Home Residents
It's a common scenario: a 90-year-old resident of a U.S. nursing home — call her Ms. B. — has moderately advanced Alzheimer's disease, congestive heart failure with severe left-ventricular dysfunction, and chronic pain from degenerative joint disease. She develops a nonproductive cough and a…
- Free Full Text
Review Article
Franklin H. Epstein Lecture: Sirtuins, Aging, and Medicine
Foreword. Franklin H. Epstein, M.D. served the New England Journal of Medicine for more than 20 years. A keen clinician, accomplished researcher, and outstanding teacher, Dr. Epstein was Chair and Professor of Medicine at Beth Israel Deaconess Medical Center, Boston, where the Franklin H. Epstein,…
Original Article
Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration
In 2005, clinical trials established the efficacy of ranibizumab, (Lucentis, Genentech) for the treatment of neovascular age-related macular degeneration (AMD), the leading cause of legal blindness in the United States. While awaiting approval for ranibizumab from the Food and Drug Administration,…
- Free Full Text
- CME
Clinical Implications of Basic Research
Fatty Acids and Retinopathy
Two common eye diseases that cause blindness are age-related macular degeneration (AMD) and diabetic retinopathy. Retinopathy of prematurity causes a lifetime of visual impairment. A recent study by Sapieha and colleagues implicates a precise molecular mechanism that underlies a hypothesis: that…
Editorial
Bevacizumab versus Ranibizumab for AMD
For 5 years, patients and clinicians have wrestled with the choice between two drugs for the treatment of neovascular age-related macular degeneration (AMD), a common cause of irreversible blindness among the elderly worldwide. Vision loss results from the abnormal growth and leakage of blood…
Perspective
Electroconvulsive Therapy in the Spotlight
In January, the Food and Drug Administration (FDA) convened a meeting of its Neurological Devices Advisory Panel to help it decide how to classify electroconvulsive therapy (ECT) devices, a decision that could determine the future of ECT in the United States. The meeting revealed sharp differences…
Perspective
Improving the Allocation System for Deceased-Donor Kidneys
On February 16, 2011, the Organ Procurement and Transplantation Network (OPTN), the federal contractor responsible for overseeing solid-organ allocation in the United States, released for public comment three proposed concepts for the allocation of kidneys from deceased donors: using a Kidney Donor…
Correspondence
Kidney Allocation and the Aging Immune Response
To the Editor: Organ allocation is a critical component in the success of transplantation. The increasing discrepancy between supply and demand is one of the most important problems in renal transplantation. Despite intensive efforts, donation rates have not increased recently. Moreover,…
- Free Full Text
Perspective
Risk, Prognosis, and Unintended Consequences in Kidney Allocation
The gap between the supply and demand of transplantable kidneys is growing, leaving policymakers eager to maximize the benefit of every kidney transplanted. Recently, a proposal for changing the way kidneys from deceased donors are allocated was proffered for public comment by the Kidney Committee…







